Big Oil’s SCOTUS Connection Sees Himself Out
An oil-backed justice bows out, location tracking gets turned off, Elon Musk loses a few bucks, Wisconsin public workers win big, and a controversial anesthesia policy is out cold.
Education
YOU LOVE TO SEE IT: Freeing Captive Audiences
Employers have to free their captives, the Feds curb a health care giant’s shopping spree, Google’s big breakup levels up, scam call crackdowns are showing results, and Facebook’s anti-shareholder effort gets blocked.
YOU LOVE TO SEE IT: Fighting The Lunchroom Bully
The Feds crack down on school lunch fees, ghost networks get summoned, a big mine gets slapped with a big fine, and America gets its ethics chief.
YOU LOVE TO SEE IT: Downballot Victories Enshrine Worker, Voter, And Reproductive Rights
Voters protected abortion rights, struck back at oligarchs, delivered public school funding, and ensured workers get their payday.
YOU LOVE TO SEE IT: A School Lending Bully Gets Expelled
Plus, the hearing-aid cartel gets muted, the country’s busiest streets are going fossil-free, and interest rates sink while spirits rise.
The Corporation Stealing Your Kid’s Lunch Money
As students head back to school, one of the largest payment processors in the world is fighting to protect the millions it makes upcharging parents on school meals.
America’s Billionaires Are Teaching Your Kids To Cheat Taxes
Corporations and arch-conservatives are using a public school curriculum to teach children about the dangers of taxing the wealthy.
Why Are Teachers Funding Billionaires’ Private Jets?
Plus, Wall Street pretends it’s in Texas, Gordon Gekko gets rich off California workers, and the launch of Summer 2024’s blockbuster event.
YOU LOVE TO SEE IT: Happy Math For Public Schools
Plus, free tax filing pays off, electric vehicles work double time, and pharmaceutical giants face scrutiny for outrageous pricing.
Universities Are Making Billions Gatekeeping Your Meds
The University of California has raked in a previously undisclosed $1.6 billion from Xtandi sales, and now doesn’t want the government lowering exorbitant drug costs.